194 related articles for article (PubMed ID: 15768340)
1. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
Doab A; Treloar C; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340
[TBL] [Abstract][Full Text] [Related]
2. The impact of injecting drug use status on hepatitis C-related referral and treatment.
Stoové MA; Gifford SM; Dore GJ
Drug Alcohol Depend; 2005 Jan; 77(1):81-6. PubMed ID: 15607844
[TBL] [Abstract][Full Text] [Related]
3. Treatment for hepatitis C virus infection among current injection drug users in Australia.
Matthews G; Kronborg IJ; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
[TBL] [Abstract][Full Text] [Related]
4. Injecting drug users' understanding of hepatitis C.
O'Brien S; Day C; Black E; Dolan K
Addict Behav; 2008 Dec; 33(12):1602-5. PubMed ID: 18762384
[TBL] [Abstract][Full Text] [Related]
5. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
6. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.
Grebely J; Genoway KA; Raffa JD; Dhadwal G; Rajan T; Showler G; Kalousek K; Duncan F; Tyndall MW; Fraser C; Conway B; Fischer B
Drug Alcohol Depend; 2008 Jan; 93(1-2):141-7. PubMed ID: 17997050
[TBL] [Abstract][Full Text] [Related]
7. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
Litwin AH; Soloway I; Gourevitch MN
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S339-45. PubMed ID: 15768345
[TBL] [Abstract][Full Text] [Related]
8. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment.
Sulkowski MS; Thomas DL
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S263-9. PubMed ID: 15768333
[TBL] [Abstract][Full Text] [Related]
10. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
Dore GJ; Thomas DL
Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
[TBL] [Abstract][Full Text] [Related]
11. Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden.
Norden L; Saxon L; Kåberg M; Käll K; Franck J; Lidman C
Scand J Infect Dis; 2009; 41(10):727-34. PubMed ID: 19688640
[TBL] [Abstract][Full Text] [Related]
12. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada.
Wozniak L; Prakash M; Taylor M; Wild TC
Int J Drug Policy; 2007 Oct; 18(5):388-96. PubMed ID: 17854727
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
Hallinan R; Byrne A; Amin J; Dore GJ
J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
[TBL] [Abstract][Full Text] [Related]
14. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland.
Ompad DC; Fuller CM; Vlahov D; Thomas D; Strathdee SA
Clin Infect Dis; 2002 Oct; 35(7):783-8. PubMed ID: 12228813
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination?
Day C; Ross J; Dolan K
Drug Alcohol Rev; 2003 Sep; 22(3):317-21. PubMed ID: 15385226
[TBL] [Abstract][Full Text] [Related]
16. Treating hepatitis C virus infection in active substance users.
Sylvestre DL
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S321-4. PubMed ID: 15768341
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.
Backmund M; Reimer J; Meyer K; Gerlach JT; Zachoval R
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S330-5. PubMed ID: 15768343
[TBL] [Abstract][Full Text] [Related]
18. Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection.
Canfield KM; Smyth E; Batki SL
Subst Use Misuse; 2010 Mar; 45(4):496-514. PubMed ID: 20141461
[TBL] [Abstract][Full Text] [Related]
19. "Eyes Wide Shut": narratives of women living with hepatitis C in Australia.
Crockett B; Gifford SM
Women Health; 2004; 39(4):117-37. PubMed ID: 15691088
[TBL] [Abstract][Full Text] [Related]
20. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
Hopwood M; Treloar C
Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
